» Articles » PMID: 16411971

Impact of Comorbidity on Ischemic Stroke Outcome

Overview
Specialty Neurology
Date 2006 Jan 18
PMID 16411971
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the impact of comorbidity on stroke outcome of patients admitted to a general ward (GW) and a stroke unit (SU).

Methods: Data of 266 patients with acute ischemic stroke (GW: 103, SU: 163) were collected prospectively for 13 months. Clinical and radiological findings, and the Charlson Comorbidity Index (CCI) were recorded. Predictors of outcome 4 months after stroke were analyzed. Favorable outcome was defined as modified Rankin Scale (mRS) score of < or = 2, unfavorable as mRS >2.

Results: The mean age of the patients was 67.2 years (SD = 14.4), the mean CCI 1.2 (SD = 1.4). In univariate analysis, small artery disease predicted favorable outcome (P < 0.001) and age (P = 0.022), high National Institutes of Health Stroke Scale (NIHSS) score (P < 0.001), high CCI (P < 0.001), treatment in a GW (P = 0.004), coronary artery disease (P = 0.02), dementia (P = 0.009), diabetes (P = 0.005) and atrial fibrillation (P < 0.001) unfavorable outcome after 4 months. In multivariate analysis, high NIHSS score (P < 0.001), atrial fibrillation (P = 0.004), coronary artery disease (P = 0.012) and diabetes (P = 0.031) were predictors of unfavorable outcome.

Conclusions: Comorbidity has a significant impact on stroke outcome. In addition to stroke severity, atrial fibrillation, coronary artery disease and diabetes were predictors of outcome after stroke, but not the sum of the CCI.

Citing Articles

Differential vulnerability among cell types in the neurovascular unit: Description and mechanisms.

Brookshier A, Lyden P J Cereb Blood Flow Metab. 2024; 45(1):3-12.

PMID: 39520113 PMC: 11563522. DOI: 10.1177/0271678X241299960.


The individual and combined impacts of pre-existing diabetes and dementia on ischemic stroke outcomes: a registry-based cohort study.

Kyaw K, Pana T, Bettencourt-Silva J, Metcalf A, Myint P, Potter J BMC Cardiovasc Disord. 2024; 24(1):396.

PMID: 39080558 PMC: 11290225. DOI: 10.1186/s12872-024-04050-3.


A prospective observational study of estimating drug related problems and clinical outcomes in subtypes of stroke patients.

Ali M, Shoaib M, Nesar S, Jamal M, Gul S, Shahnaz S PLoS One. 2024; 19(1):e0295208.

PMID: 38165875 PMC: 10760710. DOI: 10.1371/journal.pone.0295208.


Obesity-induced Ly6C and Ly6C monocyte subset changes abolish post-ischemic limb conditioning benefits in stroke recovery.

Kim I, Ju H, Minkler J, Madkoor A, Park K, Cho S J Cereb Blood Flow Metab. 2023; 44(5):689-701.

PMID: 37974299 PMC: 11197146. DOI: 10.1177/0271678X231215101.


Comparing stroke rehabilitation inpatients and clinical trials eligibility criteria: A secondary chart review analysis revealing that most patients could have been excluded from rehabilitation trials based on comorbidity status.

Nelson M, Singh H, Nie J, MacDonald S, Bayley M, Fortin C J Multimorb Comorb. 2023; 13:26335565231211668.

PMID: 37927973 PMC: 10624005. DOI: 10.1177/26335565231211668.